Loading clinical trials...

Adipose-derived SVF for Treatment of Erectile Dysfunction (ED) | Clinical Trials | Clareo Health

WITHDRAWNNA

Adipose-derived SVF for Treatment of Erectile Dysfunction (ED)

Use of Autologous Adipose-derived Stromal Vascular Fraction to Treat Erectile Dysfunction - A Safety and Feasibility Study

NCT03886402•GID BIO, Inc.

View on ClinicalTrials.gov

Summary

This study will examine the safety and feasibility of a single injection of autologous adipose-derived stromal vascular fraction to treat erectile dysfunction.

Eligibility

Age

18 - 65 years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•history of ED of at least 3 months' duration
•have been taking a Phosphodiesterase type 5 (PDE5) inhibitor for at least 1 month prior and willing to stop taking any PDE5 inhibitor for duration of study
•have an IIEF-EF domain score that is ≥11 and ≤25
•have the same sexual partner for the duration of the study
•subject and partner willing to voluntarily give consent
•speak, read and understand English

Exclusion Criteria

•non-responders to PDE5 inhibitor
•radical prostatectomy or other pelvic surgery or penile implant
•currently taking blood thinners, cancer drugs or HIV drugs
•allergic to lidocaine, epinephrine, valium
•diminished decision-making capacity
•use of tobacco
•previous pelvic or abdominal radiation therapy
•anti-androgen therapy
•untreated hypogonadism
•uncontrolled hypertension or hypotension
+2 more criteria

Locations (1)

David Matthews MD

Charlotte, North Carolina, United States

Key Dates

Start Date

October 1, 2021

Primary Completion Date

October 1, 2022

Completion Date

October 1, 2022

Last Updated

April 24, 2025

Conditions

Erectile Dysfunction

Interventions

GID SVF-2

DEVICE

Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction

NCT07480161

Erectile Dysfunction With Diabetes Mellitus

View study

RECRUITINGPHASE2

TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

NCT07460960

Erectile Dysfunction Due to Arterial DiseaseAtheroscleroses+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 24, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Adipose-derived SVF for Treatment of Erectile Dysfunction (ED)

Inclusion Criteria

Exclusion Criteria

Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction

TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction

Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED

Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction

Regenerative Injection of Stem Cells or Stem Cell-derived Exosomes for Erectile Dysfunction (RISE)